James Stocks
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
-
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Pulmonary Hypertension Research and Treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Papers in
-
- Protease and Inhibitor Mechanisms 13
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 5
- Pulmonary Hypertension Research and Treatments 2
- Co-authors
- Robert A. Sandhaus (20 shared papers)Rick Carter (4 shared papers)David B. Holiday (4 shared papers)Brian Tiep (4 shared papers)Mark Brantly (15 shared papers)Charlie Strange (12 shared papers)Carol Grothues (3 shared papers)Chiagozie Nwasuruba (2 shared papers)
- Journals
- CHEST Journal (8 papers)COPD Journal of Chronic Obstructive Pulmonary Disease (5 papers)Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation (1 paper)European Respiratory Journal (1 paper)The Lancet Respiratory Medicine (1 paper)
- Partner nations
- United StatesIrelandCanada
In The Last Decade
James Stocks
31 papers receiving 1.4k citations
James Stocks's Hit Papers
Peers
Comparison fields: 5 of 88
- Cancer Research 531
- Pulmonary and Respiratory Medicine 578
- Oncology 372
- Hematology 155
- Physiology 229
Countries citing papers authored by James Stocks
This map shows the geographic impact of James Stocks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Stocks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Stocks more than expected).
Fields of papers citing papers by James Stocks
This network shows the impact of papers produced by James Stocks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Stocks. The network helps show where James Stocks may publish in the future.
Co-authors
The 25 scholars most cited alongside James Stocks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2015 | 329 |
| 2 | 2003 | 171 | |
| 3 | 2016 | 142 | |
| 4 | 2013 | 137 | |
| 5 | 2002 | 69 | |
| 6 | 2007 | 61 | |
| 7 | 2002 | 61 | |
| 8 | 2012 | 50 | |
| 9 | 2013 | 45 | |
| 10 | 2003 | 42 | |
| 11 | 2006 | 40 | |
| 12 | 2012 | 36 | |
| 13 | 2008 | 36 | |
| 14 | Obliterative Bronchiolitis in Workers in a Coffee-Processing Facility — Texas, 2008–2012 | 2013 | 31 |
| 15 | 2007 | 30 | |
| 16 | 2010 | 29 | |
| 17 | 2003 | 24 | |
| 18 | 2012 | 20 | |
| 19 | 2013 | 15 | |
| 20 | 2021 | 13 |
About James Stocks
James Stocks is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 31 papers that have together received 1.4k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (13 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Peptidase Inhibition and Analysis (4 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Insect Resistance and Genetics (2 papers), Pulmonary Hypertension Research and Treatments (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers) and Cardiovascular Function and Risk Factors (2 papers). The work is most often cited by research in Cancer Research (531 citations), Pulmonary and Respiratory Medicine (578 citations), Oncology (372 citations), Hematology (155 citations) and Physiology (229 citations). James Stocks has collaborated with scholars based in United States, Ireland and Canada. Frequent co-authors include Robert A. Sandhaus, Rick Carter, David B. Holiday, Brian Tiep, Mark Brantly, Charlie Strange, Carol Grothues, Chiagozie Nwasuruba, James K. Stoller and Noel G. McElvaney. Their work appears in journals such as CHEST Journal, COPD Journal of Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation, European Respiratory Journal and The Lancet Respiratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.